相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
Martin Poelcher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients
M. Hoopmann et al.
EUROPEAN JOURNAL OF CANCER CARE (2010)
Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer
Timothy J. Duncan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
T Cell Density and Location Can Influence the Prognosis of Ovarian Cancer
Ahmad Al-Attar et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters
Chih-Kung Lin et al.
APMIS (2009)
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Ilona Kryczek et al.
BLOOD (2009)
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
P. de Graeff et al.
BRITISH JOURNAL OF CANCER (2009)
Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
M. Stumpf et al.
BRITISH JOURNAL OF CANCER (2009)
Intraepithelial T Cells and Tumor Proliferation
Sarah F. Adams et al.
CANCER (2009)
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
Ninke Leffers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
Min Fei et al.
CANCER INVESTIGATION (2009)
FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
Ilona Kryczek et al.
CANCER RESEARCH (2009)
Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
Niels Eckstein et al.
CANCER RESEARCH (2009)
Current status of anti-angiogenic agents in the treatment of ovarian carcinoma
Alfonso Sanchez-Munoz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Now therapeutic agents in ovarian cancer
Fiona Collinson et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2009)
c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome
Marina Bagnoli et al.
ENDOCRINE-RELATED CANCER (2009)
TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens
Izabela Ziolkowska-Seta et al.
GYNECOLOGIC ONCOLOGY (2009)
Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer
Franco Muggia
GYNECOLOGIC ONCOLOGY (2009)
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
Jennifer M. Rubatt et al.
GYNECOLOGIC ONCOLOGY (2009)
Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma
Hyo Sup Shim et al.
HUMAN PATHOLOGY (2009)
Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
Lilach Kleinberg et al.
HUMAN PATHOLOGY (2009)
Ovarian carcinoma pathology and genetics: recent advances
C. Blake Gilks et al.
HUMAN PATHOLOGY (2009)
Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer
Alain G. Zeimet et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
Johanne Weberpals et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Prognostic Value of Human Epidermal Growth Factor Receptor 2 (Her-2)/neu in Patients With Advanced Ovarian Cancer Treated With Platinum/Paclitaxel as First-Line Chemotherapy A Retrospective Evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany
Jacobus Pfisterer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
The Relationship of Platinum Resistance and ERCC1 Protein Expression in Epithelial Ovarian Cancer
Karina Dahl Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Expression and Clinical Role of Antiapoptotic Proteins of the Bag, Heat Shock, and Bcl-2 Families in Effusions, Primary Tumors, and Solid Metastases in Ovarian Carcinoma
Mari Bunkholt Elstrand et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2009)
被撤回的出版物: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (Retracted article. See vol. 65, pg. 861, 2012)
D. de Jong et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection
K. Engels et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
Blaise Clarke et al.
MODERN PATHOLOGY (2009)
Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis
Areeg Faggad et al.
MODERN PATHOLOGY (2009)
Nuclear Expression of Epidermal Growth Factor Receptor is a Novel Prognostic Value in Patients With Ovarian Cancer
Weiya Xia et al.
MOLECULAR CARCINOGENESIS (2009)
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
Henry T. Lynch et al.
MOLECULAR ONCOLOGY (2009)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
Katy Milne et al.
PLOS ONE (2009)
A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
Martin Köbel et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Joshua Z. Press et al.
BMC CANCER (2008)
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
G. Ferrandina et al.
BRITISH JOURNAL OF CANCER (2008)
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
P. de Graeff et al.
BRITISH JOURNAL OF CANCER (2008)
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
S. M. Alam et al.
BRITISH JOURNAL OF CANCER (2008)
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
Hiroaki Itamochi et al.
CANCER SCIENCE (2008)
Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma
Adelaida Garcia-Velasco et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Vascular endothelial growth factor expression in ovarian cancer: A model for targeted use of novel therapies?
Timothy J. Duncan et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma
Bo Sung Yoon et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2008)
ERCC1-immunoexpression does not predict platinum-resistance in ovarian cancer
Sylvia Stadlmann et al.
GYNECOLOGIC ONCOLOGY (2008)
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer:: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
Aristotelis Bamias et al.
GYNECOLOGIC ONCOLOGY (2008)
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
Marketa Tomsova et al.
GYNECOLOGIC ONCOLOGY (2008)
The impact of T-cell immunity on ovarian cancer outcomes
Brad H. Nelson
IMMUNOLOGICAL REVIEWS (2008)
Consortium analysis of 7 candidate SNPs for ovarian cancer
Susan J. Ramus et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Expression of hypoxia-inducible factor 1α gene affects the outcome in patients with ovarian cancer
R. Shimogai et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer
K. Lin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Alteration of cell-cycle regulation in epithelial ovarian cancer
E. J. Nam et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Epidermal growth factor receptor expression in serous ovarian carcinoma: An immunohistochemical study with galectin-3 and cyclin D1 and outcome
Hermann Brustmann
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Expression of DNA damage checkpoint protein hus1 in epithelial ovarian tumors correlates with prognostic markers
Javier De la Torre et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Is it time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer?
Noah D. Kauff
JOURNAL OF CLINICAL ONCOLOGY (2008)
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Keren Levanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
Robert L. Camp et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
Margaret S. Pepe et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas
Bernard Tetu et al.
MODERN PATHOLOGY (2008)
Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer
Rui-Xia Guo et al.
PATHOLOGY INTERNATIONAL (2008)
The prognostic significance of COX-2 and survivin expression in ovarian cancer
Pauline Athanassiadou et al.
PATHOLOGY RESEARCH AND PRACTICE (2008)
Human papilloma virus (HPV) status, p16(INK4a), and p53 overexpression in epithelial malignant and borderline ovarian neoplasms
Glovanna Giordano et al.
PATHOLOGY RESEARCH AND PRACTICE (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma
Hiep Phuc Dong et al.
CANCER (2008)
Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type
Sohei Yamamoto et al.
MODERN PATHOLOGY (2007)
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
David F. Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients
Marianne Tuefferd et al.
PLOS ONE (2007)
Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary
Julia E. Palmer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas
Georgia Levidou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma
M. Haysam Khouja et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma
Ilona Kryczek et al.
CANCER RESEARCH (2007)
Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel-Lindau protein in epitheLiaL ovarian neoplasms and allelic loss of von Hippel-Lindau gene:: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
Ryosuke Osada et al.
HUMAN PATHOLOGY (2007)
Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIα, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow
C. Schindlbeck et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy
Isabelle Bedrosian et al.
CLINICAL CANCER RESEARCH (2007)
Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma
Sunyoung Lee et al.
GYNECOLOGIC ONCOLOGY (2007)
Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer - From the Danish MALOVA Ovarian Cancer Study
Estrid V. S. Hogdall et al.
GYNECOLOGIC ONCOLOGY (2007)
An apoptotic molecular network identified by microarray:: On the TRAIL to new insights in epithelial ovarian cancer
Véronique Ouellet et al.
CANCER (2007)
Novel approaches in advancing the treatment of epithelial ovarian cancer: The role of angiogenesis inhibition
Lainie Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma
Sohei Yamamoto et al.
VIRCHOWS ARCHIV (2007)
The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer
K. D. Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: A Gynecologic Oncology Group study
Angeles Alvarez Secord et al.
GYNECOLOGIC ONCOLOGY (2007)
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes.: Association of CD3+CD56+ cells with platinum resistance
A. Bamias et al.
GYNECOLOGIC ONCOLOGY (2007)
Hypoxia inducible factor 1-α expression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancer
Hidekatsu Nakai et al.
CANCER LETTERS (2007)
Tumor markers in ovarian carcinoma
M. R. Raspollini et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2007)
Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer
Kirsi A. Suhonen et al.
EUROPEAN JOURNAL OF CANCER (2007)
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome
S. R. Kumar et al.
BRITISH JOURNAL OF CANCER (2007)
Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer
Joachim Woenckhaus et al.
VIRCHOWS ARCHIV (2007)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
Kenjiro Sawada et al.
CANCER RESEARCH (2007)
In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway
D. Pils et al.
BRITISH JOURNAL OF CANCER (2007)
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer
S. Sillanpaa et al.
GYNECOLOGIC ONCOLOGY (2007)
Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma
Naoki Sasaki et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2007)
Potential predictors of chemotherapy response in ovarian cancer - How do we define chemosensitivity?
S. A. O'Toole et al.
GYNECOLOGIC ONCOLOGY (2007)
Independent prognostic significance of cell cycle regulator proteins p16INK4a and pRb in advanced-stage ovarian carcinoma including optimally debulked patients:: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group
S. Kommoss et al.
BRITISH JOURNAL OF CANCER (2007)
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
Lilach Kleinberg et al.
CANCER (2007)
Current management of ovarian carcinosarcoma
M. S. Mano et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
SET complex in serous epithelial ovarian cancer
Veronique Ouellet et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer
Lukas A. Hefler et al.
GYNECOLOGIC ONCOLOGY (2006)
Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to β-catenin expression
Sari M. Sillanpaa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer
Josep Castellvi et al.
CANCER (2006)
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: A multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)
J. A. Green et al.
EUROPEAN JOURNAL OF CANCER (2006)
Molecular predictors of response and outcome in ovarian cancer
Silvana Canevari et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
ErbB-3 predicts survival in ovarian cancer
Berno Tanner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The prognostic value of endoglin (CD105) expression in ovarian carcinoma
C. Taskiran et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer
Veronique Ouellet et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma
Heini Lassus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma
Qinghua Wu et al.
GYNECOLOGIC ONCOLOGY (2006)
Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis
Josep Castellvi et al.
HUMAN PATHOLOGY (2006)
Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer
KA Voutilainen et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma
DG Rosen et al.
CANCER (2006)
Significance of cyclooxygenase 2 and MDR1/P-glycoprotein coexpression in ovarian cancers
Pawel Surowiak et al.
CANCER LETTERS (2006)
WTI gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study
Wirote Netinatsunthorn et al.
BMC CANCER (2006)
Expression of metalloproteinases 2 and 9 and cyclooxygenase 2 in endometrial carcinoma
MR Raspollini et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2006)
Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer
B Hylander et al.
GYNECOLOGIC ONCOLOGY (2006)
Cyclin-dependant kinase inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer
A Schmider-Ross et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival
K Ino et al.
BRITISH JOURNAL OF CANCER (2006)
Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms
EY Cho et al.
PATHOLOGY INTERNATIONAL (2006)
BURCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study
M Thrall et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma
V Karavasilis et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas
E Yakirevich et al.
GYNECOLOGIC ONCOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Perturbation of the tumor necrosis factor-related apoptosis-inducing ligand cascade in ovarian cancer:: Overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5
P Horak et al.
CLINICAL CANCER RESEARCH (2005)
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer
D Wolf et al.
CLINICAL CANCER RESEARCH (2005)
Prognostic factors in ovarian carcinoma stage III patients.: Can biomarkers improve the prediction of short- and long-term survivors?
J Kaern et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
A du Bois et al.
ANNALS OF ONCOLOGY (2005)
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic oncology group study
RJ Schilder et al.
CLINICAL CANCER RESEARCH (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
EUROPEAN JOURNAL OF CANCER (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma
I Khalifeh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2005)
The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer
MJ Goodheart et al.
CLINICAL CANCER RESEARCH (2005)
β-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer:: A study in 253 patients
W Kildal et al.
EUROPEAN JOURNAL OF CANCER (2005)
Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma
MR Raspollini et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2005)
Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival
R Ali-Fehmi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Expression of Bcl-XL in ovarian carcinoma is associated with chemoresistance and recurrent disease
J Williams et al.
GYNECOLOGIC ONCOLOGY (2005)
Opinion - Bias as a threat to the validity of cancer molecular-marker research
DF Ransohoff
NATURE REVIEWS CANCER (2005)
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters
G Ferrandina et al.
BRITISH JOURNAL OF CANCER (2005)
Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining
K Kritpracha et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2005)
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: Evaluation of its prevalence and prognostic significance - Clinical study
E Verri et al.
ONCOLOGY (2005)
Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas
Y Wang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Prognostic factors responsible for survival in sex cord stromal tumors of the ovary - A multivariate analysis
JK Chan et al.
GYNECOLOGIC ONCOLOGY (2005)
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
NK Noren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Expression of Cox-2, CD34, bcl-2, and p53 and survival in patients with primary peritoneal serous carcinoma and primary ovarian serous carcinoma
I Khalifeh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer
SS Seo et al.
GYNECOLOGIC ONCOLOGY (2004)
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome
MR Raspollini et al.
GYNECOLOGIC ONCOLOGY (2004)
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma
TL Erkinheimo et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas
C Faleiro-Rodrigues et al.
ANNALS OF ONCOLOGY (2004)
Loss of β-catenin is associated with poor survival in ovarian carcinomas
C Faleiro-Rodrigues et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2004)
Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma
MR Raspollini et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
Remaining controversies in the upfront management of advanced ovarian cancer
MS Mano et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)
C Elie et al.
BRITISH JOURNAL OF CANCER (2004)
Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer
A Bali et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer
JS Nielsen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
Platinums: Extending their therapeutic spectrum
FM Muggia et al.
JOURNAL OF CHEMOTHERAPY (2004)
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
S Camilleri-Broet et al.
ANNALS OF ONCOLOGY (2004)
Vascular endothelial growth factor expression in serous ovarian carcinoma:: relationship with topoisomerase IIα and prognosis
H Brustmann
GYNECOLOGIC ONCOLOGY (2004)
Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer
F Barbieri et al.
ONCOLOGY (2004)
The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma
R Ali-Fehmi et al.
CANCER (2003)
The influence of microvessel density on ovarian carcinogenesis
PJB Stone et al.
GYNECOLOGIC ONCOLOGY (2003)
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens
J Plisiecka-Halasa et al.
ANNALS OF ONCOLOGY (2003)
Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma - From the Danish MALOVA ovarian cancer study
EVS Hogdall et al.
CANCER (2003)
Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis
C Cohen et al.
MODERN PATHOLOGY (2003)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer
K Milde-Langosch et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2003)
Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries -: Correlation with clinicopathologic factors and survival
GÖ Elpek et al.
APMIS (2003)
Evaluation of clinical significance of TP53, BCL-2, BAX and MEKI expression in 229 ovarian carcinomas treated with platinum-based regimen
J Kupryjanczyk et al.
BRITISH JOURNAL OF CANCER (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer
RAM Sagarra et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
G Ferrandina et al.
ANNALS OF ONCOLOGY (2002)
Ovarian cancer p53 mutation is associated with tumor microvessel density
MJ Goodheart et al.
GYNECOLOGIC ONCOLOGY (2002)
The combined evaluation of p27Kip1 and Ki-67 expression provides independent information on overall survival of ovarian carcinoma patients
P Korkolopoulou et al.
GYNECOLOGIC ONCOLOGY (2002)
The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy
I Skirnisdóttir et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma
S Ogawa et al.
CANCER LETTERS (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Differential expression of bcl-2 family proteins in bladder carcinomas relationship with apoptotic rate and survival
P Korkolopoulou et al.
EUROPEAN UROLOGY (2002)
Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma
C Denkert et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer:: a multifactorial analysis of TP53, p21, BAX and BCL-2
M Schuyer et al.
BRITISH JOURNAL OF CANCER (2001)
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications
B Davidson et al.
GYNECOLOGIC ONCOLOGY (2001)
Implication of malignancy and prognosis of p27kip1, cyclin E, and Cdk2 expression in epithelial ovarian tumors
L Sui et al.
GYNECOLOGIC ONCOLOGY (2001)
Expression of cell cycle regulators p57KIP2, cyclin D1, and cyclin E in epithelial ovarian tumors and survival
E Rosenberg et al.
HUMAN PATHOLOGY (2001)
Thrombospondin-1 expression in epithelial ovarian carcinoma:: Association with p53 status, tumor angiogenesis, and survival in platinum-treated patients
AA Alvarez et al.
GYNECOLOGIC ONCOLOGY (2001)
Topoisomerase II immunostaining as a prognostic marker for survival in ovarian cancer
WH Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2001)
Ovarian surface epithelium: Biology, endocrinology, and pathology
N Auersperg et al.
ENDOCRINE REVIEWS (2001)
The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma
I Skirnisdóttir et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
P53, bcl-2, and bax:: Their relationship and effect on prognosis in early stage epithelial ovarian carcinoma
I Skirnisdóttir et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2001)
p53 And related proteins in epithelial ovarian cancer
PS Sengupta et al.
EUROPEAN JOURNAL OF CANCER (2000)
E-cadherin complex protein expression and survival in ovarian carcinoma
B Davidson et al.
GYNECOLOGIC ONCOLOGY (2000)
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer
M Baekelandt et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas
H Blegen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2000)
Inverse expression of cdk4 and p16 in epithelial ovarian tumors
L Sui et al.
GYNECOLOGIC ONCOLOGY (2000)
Topoisomerase IIα:: Prognostic predictor and cell cycle marker in surface epithelial neoplasms of the ovary and peritoneum
MJ Costa et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2000)
p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma
A Schmider et al.
GYNECOLOGIC ONCOLOGY (2000)
Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors
M Shimizu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2000)
Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epithelial ovarian neoplasms
S Munakata et al.
BRITISH JOURNAL OF CANCER (2000)
p53 and bcl-2 in epithelial ovarian carcinoma: Their value as prognostic indicators at a median follow-up of 60 months
JP Geisler et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
